Arkolith/Insider Trading/LENZ/Form 4

Versant Venture Capital VI, L.P.

10% OwnerLENZ Therapeutics, Inc. (LENZ) · full profile →Form 4 · filed Aug 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10.3M
Net Open-Market Flow
-$10.3M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2025Sell(S)15K$38.56$582K963K
Aug 18, 2025Sell(S)31K$38.56$1.2M1.4M
Aug 15, 2025Sell(S)70K$39.50$2.8M978K
Aug 15, 2025Sell(S)145K$39.50$5.7M1.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-110163) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML